LH: 徕博科

LH新闻

• 16:37 Myriad Genetics将陷入困境的产前业务部门以2.1亿美元出售给Labcorp
• 16:37 Myriad Genetics Offloads Struggling Prenatal Unit for $210 Million to Labcorp
• 12:35 Myriad Genetics To Sell Its Prenatal Health Testing Business, Including Prequel, Foresight, SneakPeek And FirstGene Tests, To Labcorp For $210M In Cash Plus Inventory Value
• 14:20 OPKO Health to Sell Select BioReference Assets to Labcorp for $722M
• 10:52 PACS Group, Inc. (PACS) Surges 6.2%: Is This an Indication of Further Gains?
• 15:41 OPKO Health Sheds Diagnostics Businesses in Major Labcorp Deal
• 12:21 UPDATE: Labcorp Agrees To Acquire Select Assets Of OPKO Health's BioReference Health Subsidiary For $722M In Cash, Up To Additional $150M In Earnout On Revenue
• 12:12 Should You Add Abbott Stock to Your Portfolio Ahead of Q3 Earnings?
• 12:00 What to Expect From Labcorp Holdings’ Q3 2026 Earnings Report
• 15:52 Natera: Priced To Perfection Amidst Rising Competitive Threats (NASDAQ:NTRA)
• 12:40 Here's Why Labcorp Holdings (LH) is a Strong Value Stock
• 13:31 DHR's Growth Backed by Strong Biotechnology Unit: Can It Maintain the Pace?
• 11:44 Is This the Right Time to Add Labcorp Stock to Your Portfolio?
• 18:58 Labcorp: The CMS Selloff Represents An Excellent Opportunity - Strong Buy (NYSE:LH)
• 06:16 Is Labcorp Holdings Stock Outperforming the Dow?
• 21:53 Labcorp's Future Driven By Clinical Testing Demand, Despite Impact From Medicare Cuts (LH)
• 20:46 Labcorp Reaffirms 2026–2029 Long-Term Outlook Following CMS Preliminary Medicare Payment Rate Release; Expects Compound Annual Adj EPS Growth Of 8.5%-11.5% In 2026-2029
• 20:46 Labcorp重申2026-2029年长期前景，随着CMS初步发布的Medicare支付率，预计2026-2029年每股调整后年复合增长率为8.5%-11.5%
• 20:34 Stocks Settle Mixed as Chipmakers Climb and Financial Stocks Fall
• 15:22 Stocks Mixed as Crude Oil Prices and Financial Stocks Fall
• 14:15 Stocks Supported as Crude Oil Prices Ease
• 11:56 Is Quest Diagnostics Stock Outperforming the Nasdaq?